International Drug Discovery & Clinical Research Private Limited - Company Profile

It is a education private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About International Drug Discovery & Clinical Research Private Limited

International Drug Discovery & Clinical Research Private Limited, a active private limited company, was established on 09 November 2009 in Hyderabad, Telangana, India. Engaging in k-12 & higher education institutions within the professional, scientific and technical sector, it holds CIN: U73100TG2009PTC065747. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.73 M.

Formerly known as Laxai Clinical Research Private Limited. It upholds a compliant status. Its leadership includes Vasudevan Vijayalakshmi (Director), Ahamed Kabeer Zackriyah (Director). Past directors included Reddy Gopalakrishna Nandela, Shailesh M Dave, Vamsidhar Maddipatla. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at H.No.#8-2-293/82/J/A/105, Plot No.105A Journalist Colony,Jubilee Hills, Hyderabad, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100TG2009PTC065747

  • Registration Number

    065747

  • Incorporation Date

    09 November 2009

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.73 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.73 M
  • Company Age 16 Year, 4 Months
  • Last Filing with ROC 31 Mar 2019
  • Revenue Growth **** -48.77%
  • Profit Growth **** -64.81%
  • Ebitda **** -6252.64%
  • Net Worth -58.94%
  • Total Assets -63.67%
Company report

International Drug Discovery & Clinical Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into International Drug Discovery & Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at International Drug Discovery & Clinical Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Vasudevan Vijayalakshmi Director 27 Aug 2015 Current
Ahamed Kabeer Zackriyah Director 27 Aug 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Aug 2015 Past
Pramod Abcsdd Director 31 Aug 2013 Past
Pramod Abcsdd Director 31 Aug 2015 Past
Pramod Abcsdd Director 20 Jan 2015 Past
Pramod Abcsdd Additional Director 29 Aug 2015 Past
Pramod Abcsdd Director 19 Jan 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of International Drug Discovery & Clinical Research.

International Drug Discovery & Clinical Research Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 48.77% decrease. The company also saw a substantial fall in profitability, with a 64.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 58.94%.

International Drug Discovery & Clinical Research revenue growth over time
International Drug Discovery & Clinical Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -48.77%
*******
*******
*******
*******
Revenue from Operations
*******
 -48.77%
*******
*******
*******
*******
Total Assets
*******
 -63.67%
*******
*******
*******
*******
Profit or Loss
*******
 -64.81%
*******
*******
*******
*******
Net Worth
*******
 -58.94%
*******
*******
*******
*******
EBITDA
*******
 -6252.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of International Drug Discovery & Clinical Research?

In 2019, International Drug Discovery & Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at International Drug Discovery & Clinical Research?

Unlock and access historical data on people associated with International Drug Discovery & Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of International Drug Discovery & Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped International Drug Discovery & Clinical Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on International Drug Discovery & Clinical Research
Recent Activity within the Organization
  • Annual General Meeting

    International Drug Discovery & Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity International Drug Discovery & Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was completed.

  • Director Appointment

    Vasudevan Vijayalakshmi was appointed as a Director was appointed as a Director on 27 Aug 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

  • Director Appointment

    Ahamed Kabeer Zackriyah was appointed as a Director was appointed as a Director on 27 Aug 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on International Drug Discovery & Clinical Research Private Limited was registered on 09 Nov 2009 with Roc Hyderabad & aged 16 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of International Drug Discovery & Clinical Research Private Limited?

The CIN of International Drug Discovery & Clinical Research Private Limited is U73100TG2009PTC065747.

Where is International Drug Discovery & Clinical Research Private Limited headquartered?

International Drug Discovery & Clinical Research Private Limited is headquartered at H.No.#8-2-293/82/J/A/105, Plot No.105A Journalist Colony,Jubilee Hills, Hyderabad, Telangana, 500033.

When was International Drug Discovery & Clinical Research Private Limited incorporated?

International Drug Discovery & Clinical Research Private Limited was incorporated on 09 November 2009.

Who are the current directors of International Drug Discovery & Clinical Research Private Limited?

The current directors of International Drug Discovery & Clinical Research Private Limited are

What is the primary industry of International Drug Discovery & Clinical Research Private Limited?

The primary industry of International Drug Discovery & Clinical Research Private Limited is Professional, Scientific And Technical.

Is International Drug Discovery & Clinical Research Private Limited a listed company?

International Drug Discovery & Clinical Research Private Limited is unlisted.

What is the capital structure of International Drug Discovery & Clinical Research Private Limited?

The authorized capital of International Drug Discovery & Clinical Research Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.73 M.

What is the compliance status of International Drug Discovery & Clinical Research Private Limited?

The compliance status of International Drug Discovery & Clinical Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available